Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

China Pharma Holdings (CPHI) Tax Provisions (2016 - 2018)

China Pharma Holdings filings provide 9 years of Tax Provisions readings, the most recent being $1921.0 for Q4 2018.

  • On a quarterly basis, Tax Provisions fell 93.71% to $1921.0 in Q4 2018 year-over-year; TTM through Dec 2018 was -$109989.0, a 189.69% decrease, with the full-year FY2018 number at -$109989.0, down 189.69% from a year prior.
  • Tax Provisions hit $1921.0 in Q4 2018 for China Pharma Holdings, up from -$160485.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $243131.0 in Q4 2016 to a low of -$160485.0 in Q3 2018.
  • Median Tax Provisions over the past 5 years was $1921.0 (2018), compared with a mean of $8447.8.
  • Biggest five-year swings in Tax Provisions: surged 8718.61% in 2016 and later plummeted 614.41% in 2018.
  • China Pharma Holdings' Tax Provisions stood at -$19284.0 in 2014, then skyrocketed by 85.37% to -$2821.0 in 2015, then surged by 8718.61% to $243131.0 in 2016, then plummeted by 87.45% to $30525.0 in 2017, then tumbled by 93.71% to $1921.0 in 2018.
  • The last three reported values for Tax Provisions were $1921.0 (Q4 2018), -$160485.0 (Q3 2018), and $22590.0 (Q2 2018) per Business Quant data.